Velphoro FDA Approval History
FDA Approved: Yes (First approved November 27, 2013)
Brand name: Velphoro
Generic name: sucroferric oxyhydroxide
Dosage form: Chewable Tablets
Company: Vifor Fresenius Medical Care Renal Pharma
Treatment for: Hyperphosphatemia of Renal Failure
Velphoro (sucroferric oxyhydroxide) is a chewable, iron-based phosphate binder for the control of serum phosphorus levels in patients with Chronic Kidney Disease (CKD) on dialysis.
Development timeline for Velphoro
| Date | Article |
|---|---|
| Nov 30, 2013 | Approval Velphoro Receives US FDA Approval for the Treatment of Hyperphosphatemia in Chronic Kidney Disease Patients on Dialysis |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
